Articles

Genetic counseling as a profession began in 1969 with the establishment of the first master’s level graduate program in genetic counseling; as a process, however, it has evolved over a longer period of time. Read More ›

It’s a busy time in the world of oncology as this issue of The Oncology Nurse-APN/PA (TON) comes together... Read More ›

When the fourth Illumina Discovery Symposium was presented in San Diego in conjunction with the 2014 meeting of the American Association for Cancer Research (AACR), I was fortunate to be invited to attend. The symposium focused on the progress being made in monitoring cancer through next-generation sequencing technologies. From my perspective as a patient advocate, there were several issues, concerns, and insights presented that caught my attention. Read More ›

The Cancer Hospital of New Jersey at Robert Wood Johnson University Hospital (RWJUH) is the flagship hospital of the Rutgers Cancer Institute of New Jersey. It is the only comprehensive cancer center in New Jersey designated by the National Cancer Institute. Read More ›

Onco360, the largest independent provider of Oncology Pharmacy Services in the U.S., announced today that Bill Gittinger has joined the organization as a National Director for its Managed Care business. Read More ›

The Oncology Nursing Society (ONS) 39th Annual Congress attracted almost 3000 attendees from the United States and other parts of the world. Interviews with a random sample of attendees revealed that a common theme about what drew them to the meeting was the desire to expand their horizons—to gain new knowledge, meet new people, or to breathe new life into their careers. Read More ›

The American Cancer Society estimates that 24,050 new cases of multiple myeloma (MM) will be diagnosed in the United States in 2014 and that MM will cause approximately 11,090 deaths. The 5-year survival rate, by year of diagnosis, for people with MM has improved in recent decades in the United States (1985-1989, 27.4%; 1995, 33.4%; 2005, 44.9%2), and several treatment options are currently available. Read More ›

Angela Long is the founder and creator of Breast Investigators. Breast Investigators serves as a comprehensive resource guide to help those affected by breast cancer readily gain access to quality information, care, assistance, and support. Read More ›

Conferences: What can be said about them? They are absolutely necessary for challenges, progress, and outcomes that will contribute to better evidence-based treatment for patients. Read More ›

Several new drugs for the treatment of chronic lymphocytic leukemia (CLL) are considered major advances: 2 have been approved and 2 are under review by the US Food and Drug Administration (FDA). Read More ›